6505--Alendronate Tablets Effective 05/21/2026 - 05/20/2027 36E79725R0069
Summary
AI-generated · Oct 24, 2025Procurement is for Alendronate tablets to support VA, BOP, and IHS, with a single contractor responsible for an uninterrupted supply for a 1-year term plus four pre-priced option years. Items will be distributed through the VA Pharmaceutical Prime Vendor Programs. Offerors must specify the exact drug name as it appears on the label and provide a unique NDC/UPC; standard packaging is blister packs, but unit-of-use bottles will also be accepted.
The solicitation will be issued in commercial item format (FAR Part 12) and posted electronically; no paper copies will be provided, and updates will be available on beta.SAM.gov. All responsible sources may submit proposals. Estimated annual requirements cover four item configurations: Alendronate 35 mg tablets (4 packs) with about 21,300 units; Alendronate 35 mg tablets (12 packs) with about 5,354 units; Alendronate 70 mg tablets (4 packs) with about 80,074 units; and Alendronate 70 mg tablets (12 packs) with about 100,609 units.
Presolicitation Notice Page 1 of Presolicitation Notice Page 1 of 3 Presolicitation Notice *=Required Field Presolicitation Notice Page 4 of 4 DESCRIPTION Presolicitation Notice Presolicitation Notice Page 3 of 3 Page 1 of 4 Page 1 of 4 Presolicitation Notice *=Required Field Presolicitation Notice Page 1 of 3 Page 1 of Page 1 of PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0069 for an unrestrictive procurement for Alendronate Tablets for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. The standard package is a blister pack, but VA will accept unit of use bottles. Solicitation #36E79725R0069 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 28, 2025, with a tentative closing date of November 13, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov. The estimated annual requirements are as follows: ITEM DESCRIPTION PACKAGE SIZE (BOTTLES/BLISTER PACKS) TOTAL ESTIMATED ANNUAL USAGE (BOTTLES/BLISTER PACKS) 1 ALENDRONATE 35MG TAB 4 21,300 2 ALENDRONATE 35MG TAB 12 5,354 3 ALENDRONATE 70MG TAB 4 80,074 4 ALENDRONATE 70MG TAB 12 100,609
From Presolicitation posted on Oct 23, 2025N/A
From Solicitation posted on Oct 28, 2025Notice history
3-
-
Solicitation Posted Oct 28, 2025View changes (3)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Set-Aside: None → None
-
Award Notice LATEST Posted Jan 08, 2026
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| MARLEX PHARMACEUTICALS INC | VSSNJEFMPLB3 | 1TAP7 | NEW CASTLE |
Contacts
Michael Olszewski
Phone